Search - tctmd.com

Displaying 261 - 280 of 324

Sort: Relevancy | Date

News Daily News

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

February 25, 2016

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

December 10, 2015

News Industry News

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

November 30, 2015

News Daily News

FDA Warns of Potentially Serious Problems With Intravascular Device Coatings

November 22, 2015

News Conference News AHA 2015

PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD

November 10, 2015

News Features

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

Yael L. Maxwell

November 01, 2015

News Opinion Fellow Talk

A Fellow’s Take on Technology: Looking Closer at the CardioMems and CardioHelp Devices

Sarah Elsayed, MD

October 28, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

October 11, 2015

News Daily News

Patients With Acute Pulmonary Embolism Fare Better With More-Targeted Thrombolysis

September 10, 2015

News Daily News

A los Pacientes Con Embolismos Pulmonares Agudos les Va Mejor con Trombolisis Más Dirigida

September 10, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

July 13, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

July 13, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.